Summary & Overview
HCPCS Q4101: Apligraf Skin Substitute, Per Square Centimeter
HCPCS Level II code Q4101 denotes Apligraf billed per square centimeter as an add-on product used in the management of wounds requiring a biologic skin substitute. Nationally, the code matters because it standardizes reporting for a costly, product-based intervention that is used across outpatient wound care, surgical, and dermatologic settings. Proper use of the code affects coverage determinations and claim adjudication for a specialty supply applied in addition to primary procedures.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for Apligraf use, typical sites of service where the product is applied, and the implications for billing as an add-on supply. The publication provides benchmarks for utilization and reimbursement patterns, summarizes relevant policy updates that influence coverage decisions, and outlines documentation and coding considerations tied to the add-on nature of the product.
This resource is intended for billing specialists, revenue cycle leaders, and clinicians involved with wound care to clarify what Q4101 represents, where it is commonly used, and what topics to review when managing claims for biologic skin substitute products.
Billing Code Overview
HCPCS Level II code Q4101 represents Apligraf, billed per square centimeter as an add-on product to be reported in addition to a primary procedure. The code describes a biologic skin substitute product used in wound care and dermatologic procedures where Apligraf is applied to a patient's wound bed.
-
Service type: Biologic skin substitute application and related supply
-
Typical site of service: Outpatient wound care centers, hospital outpatient departments, ambulatory surgical centers, and physician offices where topical or graft-based wound treatments are performed.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 64-year-old patient with a chronic, non-healing full-thickness venous leg ulcer present for 5 months is evaluated in a wound care clinic. Conservative measures including compression therapy, debridement, local wound care, and advanced topical dressings have failed to achieve epithelialization. After multidisciplinary review, the wound care physician documents that the ulcer is suitable for a cellular/tissue-based product. The clinic schedules an outpatient procedure to apply a bioengineered skin substitute, billed using Q4101 per square centimeter as an add-on supply charge in addition to the primary procedure. During the visit the wound is measured, debrided as needed, hemostasis is obtained, and Q4101 is applied to cover the defect. The product is sized and billed by the exact square centimeters used. The typical site of service is an ambulatory surgical center or hospital outpatient department, and can also occur in a wound clinic associated with an outpatient facility when facility billing rules permit. Common documentation elements include wound measurements, prior conservative therapy details, indication for the tissue product, description of debridement and preparation, product lot numbers, area (cm2) applied, informed consent, and any immediate post-application instructions or dressings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 |